Upstate Active Clinical Trials

Study Title:

Alliance A031201-Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

What is the purpose of the study?

This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone acetate, and prednisone in treating patients with castration-resistant metastatic prostate cancer.

Upstate Institutional Review Board (IRB) Number:

566147

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Sam Benjamin, MD

ClinicalTrials.Gov ID:

NCT01949337

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Wendy S Barry
Phone: 315-464-8271
Email: barryw@upstate.edu

Return to Previous Page || Search Again